I. O. Oresanya And İ. Erdoğan Orhan, "Deciphering Neuroprotective Effect of Rosmarinus officinalis L. (syn. Salvia rosmarinus Spenn.) through Preclinical and Clinical Studies," CURRENT DRUG TARGETS , vol.25, no.5, pp.330-352, 2024
Oresanya, I. O. And Erdoğan Orhan, İ. 2024. Deciphering Neuroprotective Effect of Rosmarinus officinalis L. (syn. Salvia rosmarinus Spenn.) through Preclinical and Clinical Studies. CURRENT DRUG TARGETS , vol.25, no.5 , 330-352.
Oresanya, I. O., & Erdoğan Orhan, İ., (2024). Deciphering Neuroprotective Effect of Rosmarinus officinalis L. (syn. Salvia rosmarinus Spenn.) through Preclinical and Clinical Studies. CURRENT DRUG TARGETS , vol.25, no.5, 330-352.
Oresanya, Ibukun, And İLKAY ERDOĞAN ORHAN. "Deciphering Neuroprotective Effect of Rosmarinus officinalis L. (syn. Salvia rosmarinus Spenn.) through Preclinical and Clinical Studies," CURRENT DRUG TARGETS , vol.25, no.5, 330-352, 2024
Oresanya, Ibukun O. And Erdoğan Orhan, İLKAY E. . "Deciphering Neuroprotective Effect of Rosmarinus officinalis L. (syn. Salvia rosmarinus Spenn.) through Preclinical and Clinical Studies." CURRENT DRUG TARGETS , vol.25, no.5, pp.330-352, 2024
Oresanya, I. O. And Erdoğan Orhan, İ. (2024) . "Deciphering Neuroprotective Effect of Rosmarinus officinalis L. (syn. Salvia rosmarinus Spenn.) through Preclinical and Clinical Studies." CURRENT DRUG TARGETS , vol.25, no.5, pp.330-352.
@article{article, author={Ibukun Oluwabukola Oresanya And author={İLKAY ERDOĞAN ORHAN}, title={Deciphering Neuroprotective Effect of Rosmarinus officinalis L. (syn. Salvia rosmarinus Spenn.) through Preclinical and Clinical Studies}, journal={CURRENT DRUG TARGETS}, year=2024, pages={330-352} }